Pharmaceutical companies—including Eli Lilly and Novo Nordisk, which currently dominate the obesity market—have been testing ...

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

Most U.S. stocks climbed Thursday, but the worst drop for UnitedHealth Group in a quarter of a century kept Wall Street in ...

Wall Street stocks ended mixed on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade ...

Most U.S. stocks rose, but the worst drop for UnitedHealth Group in a quarter century kept Wall Street in check.

U.S. stocks saw mixed movements as UnitedHealth plunged 22% after a weak earnings report, dragging the Dow down 527 points.

The UnitedHealth slide weighed heavily on the Dow, which fell 500 points, or 1.3%, Thursday morning.

The S&P 500 ended higher on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations ...

The major U.S. equities indexes were mixed at midday Thursday, with the Dow Jones Industrial Average down close to 400 points ...

Eli Lilly and Company (LLY) is currently at $852.76, up $117.87 or 16.04% --Would be highest close since March 24, 2025, when it closed at $864.90 --On pace for largest percent increase since June 29, ...

U.S. stocks are holding steadier in the final day of trading for their holiday-shortened week. The S&P 500 rose 0.2% Thursday ...